ACUTE GOUTY ARTHRITIS
Clinical trials for ACUTE GOUTY ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE GOUTY ARTHRITIS trials appear
Sign up with your email to follow new studies for ACUTE GOUTY ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gout drug aims to beat standard treatment in pain showdown
Symptom relief Recruiting nowThis study tests a new medicine called ABP-745 to see if it reduces pain and swelling from an acute gout flare better than the standard drug colchicine or a placebo. About 380 adults aged 18 to 70 who have had at least two gout flares in the past year will take part. The main goa…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
New gout drug aims to stop flare pain in 72 hours
Symptom relief Recruiting nowThis study tests an experimental drug, punarlimab, for people with acute gouty arthritis. About 170 adults who have had at least three gout flares in the past year will receive either the new drug or an active comparator. The main goal is to see if punarlimab reduces pain within …
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC